IVF service market is expected to reach $ 829.5 million in 2023, with a CAGR of 18.2% | Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd. and oth

The IVF service market in India is expected to grow considerably in the future due to an increase in the incidence of infertility cases, an increase in the tendency of women to delay pregnancy, and an increase in spouse donations. In addition, inexpensive clinical settings for IVF treatment in India compared to IVF treatment facilities in the US, UK and other pre-existing markets, market growth with rising popularity of medical and fertilizer tourism combined with advanced IVF facilities and treatment options.

The IVF service market in India is valued at $ 260 million in 2016 and is expected to reach $ 829.5 million in 2023, with a CAGR of 18.2% from 2017 to 2023. Contemporary lifestyle, increased infertility rates between couples, increased median spending Advanced and advanced classes for IVF treatment are key factors driving market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2172

In terms of end users, the Infertility Clinic sector accounted for approximately 61% of India's IVF services market revenue in 2016 and is expected to remain dominant over the forecast period. The segment also performed 77.4 million cycles in 2016, reaching 245.4 million units by 2023, with an annual average growth rate of 17.9%, the highest number of IVF cycles. This is due to the fact that infertility clinics offer a broad range of technically advanced infertility treatments under a single roof for patients.

Depending on the type of cycle, the new IVF cycle segment (non-donors) has the highest sales of $ 181.1 million in 2016 and has grown to $ 1,620 million, or $ 1,620 million, is expected. In addition, this sector is expected to reach 239.600 cycles by 2023, with a fresh IVF cycle (non-donor) of 80.1 million in 2016 in the IVF service market in India, growing by 16.9% annually from 2017 to 2023.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/2172

Key Findings of the India Ivf Services Market:
• Based on cycle type, in 2016, fresh IVF cycle (non-donor) segment accounted for around 70% share of the total market, in terms of revenue
• Thawed IVF cycle (non-donor) is projected to be the one of the fastest growing segments, registering a CAGR of 19.6% from 2017 to 2023, in terms of revenue
• Based on gender, in 2016, the female infertility segment, in terms of volume, accounted for more than 70% share of the total market.
• Based on IVF procedures, in 2016, non-ICSI IVF accounted for the highest revenue, thereby registering a CAGR of 19.2% from 2017 to 2023.

The prominent companies, hospitals, surgical centers, fertility centers, and clinical research institutes profiled in this report include Sun Pharmaceuticals Industries Ltd., Lab IVF Asia Pte. Ltd., LG Life Sciences, Cadila Pharmaceuticals Ltd., Bourn Hall Clinic, Morpheus Life Sciences Pvt. Ltd., Southend Fertility and IVF Centre, Nova IVI Fertility, Bloom Fertility Center, Manipalankur Andrology and Reproductive Medicine, Cloudnine Hospitals, Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.) Milann, and Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.).

Other players (profiles not included in the report) in the value chain analysis include, Apollo Hospitals, Fortis Hospitals, Ruby Hall IVF & Endoscopy Center., and others.

Access Full Summery @ https://www.alliedmarketresearch.com/india-ivf-services-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.